PET Imaging of Brain 5-HT(1A) Receptors Using [(11)C](-)-RWAY
|ClinicalTrials.gov Identifier: NCT00263523|
Recruitment Status : Completed
First Posted : December 8, 2005
Last Update Posted : July 2, 2017
This study will use positron emission tomography (PET) and magnetic resonance imaging (MRI) to measure a serotonin receptor subtype in the brain called 5-HT(1A). This receptor is a target for drug therapy to treat anxiety and depression. The study will see if a newly developed radioligand (radioactive substance used in PET scanning to study the receptor systems of the brain) called [(11)C](-)-RWAY is more effective than other radioligands currently used in brain receptor research.
Healthy subjects 18-40 years of age may be eligible for this study. Candidates are screened with a physical examination, electrocardiogram, and blood and urine tests.
Participants undergo PET and MRI scanning as follows:
PET uses small amounts of a radioactive chemical called a tracer (in this case, [(11)C](-)-RWAY) that "labels" active areas of the brain. For the procedure, the subject lies on the scanner bed. A special mask is fitted to the subject's head and attached to the bed to help keep the head still during the scan so the images will be clear. A brief scan is done just before the tracer is injected to provide measures of the brain that will help in the precise calculation of information from subsequent scans. Then, the tracer is injected through a catheter (plastic tube) placed in the arm and pictures are taken for about 2 hours, while the subject lies still on the scanner bed. Subjects return to the clinic for blood and urine tests 24 hours after the scan.
The MRI scan is done within 1 year of the PET scan. MRI uses a magnetic field and radio waves to produce images of body tissues and organs-in this case, the brain. The subject lies on a table that is moved into the scanner (a tube-like device), wearing earplugs to muffle the noise of the machine during the scanning process. The space in the scanner is confining and may cause some people to be somewhat anxious. An intercom system allows the subject to speak with the staff member performing the study at all times during the procedure, and the procedure can be stopped at any time.
|Condition or disease||Intervention/treatment||Phase|
|Healthy Volunteers||Drug: [11C] (-)-RWAY||Phase 1|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||15 participants|
|Official Title:||PET Imaging of Brain 5-HT1A Receptors Using [11C](-)-RWAY|
|Study Start Date :||December 5, 2005|
|Study Completion Date :||August 15, 2007|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00263523
|United States, Maryland|
|National Institutes of Health Clinical Center, 9000 Rockville Pike|
|Bethesda, Maryland, United States, 20892|